Understanding the molecular basis of the interaction between NDPK-A and AMPK α1

Molecular and Cellular Biology

Volumn 26, Issue 15, 2006, Pages 5921-5931

  Crawford, Russell M ^a   Treharne, Kate J ^a   Arnaud Dabernat, Sandrine ^b   Daniel, Jean Yves ^b   Foretz, Marc ^c   Viollet, Benoit ^c   Mehta, Anil ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE TRIPHOSPHATE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1; ISOPROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; NUCLEOSIDE DIPHOSPHATE KINASE B; NUCLEOSIDE TRIPHOSPHATE; PROTEIN HISTIDINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CATALYST; CELL ACTIVITY; CELL ENERGY; CHEMICAL REACTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; FATTY ACID SYNTHESIS; HUMAN; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SUBSTRATE CHANNELING;

ANIMALS; HUMANS; ISOENZYMES; MICE; MICE, KNOCKOUT; MULTIENZYME COMPLEXES; NUCLEOSIDE-DIPHOSPHATE KINASE; PEPTIDES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; RATS;

EID: 33746570078     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00315-06     Document Type: Article

References (34)

1. Arnaud-Dabernat, S., P. M. Bourbon, A. Dierich, M. Le Meur, and J. Y. Daniel. 2003. Knockout mice as model systems for studying nm23/NDP kinase gene functions. Application to the nm23-M1 gene. J. Bioenerg. Biomembr. 35:19-30.
2. Biondi, R. M., M. Engel, M. Sauane, C. Welter, O. G. Issinger, L. Jimenez de Asua, and S. Passeron. 1996. Inhibition of nucleoside diphosphate kinase activity by in vitro phosphorylation by protein kinase CK2. Differential phosphorylation of NDP kinases in HeLa cells in culture. FEBS Lett. 399:183-187.
3. Bosnar, M. H., J. De Gunzburg, R. Bago, L. Brecevic, I. Weher, and J. Pavelic. 2004. Subcellular localization of A and B Nm23/NDPK subunits. Exp. Cell Res. 298:275-284.
4. 3a. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Caligo, M. A., G. Cipollini, L. Fiore, S. Calvo, F. Basolo, P. Collecchi, F. Ciardiello, S. Pepe, M. Petrini, and G. Bevilacqua. 1995. NM23 gene expression correlates with cell growth rate and S-phase. Int. J. Cancer 60:837-842.
6. Crawford, R. M., H. J. Ranki, C. H. Botting, G. R. Budas, and A. Jovanovic. 2002. Creatine kinase is physically associated with the cardiac ATP-sensitive K+ channel in vivo. FASEB J. 16:102-104.
7. Crawford, R. M., K. J. Treharne, O. G. Best, R. Muimo, C. E. Riemen, and A. Mehta. 2005. A novel physical and functional association between nucleoside diphosphate kinase H1 and AMP-activated protein kinase alpha1 in liver and lung. Biochem. J. 392:201-209.
8. Crawford, R. M., K. J. Treharne, O. G. Best, C. E. Riemen, R. Muimo, D. C. Gruenert, S. Arnaud-Dabernat, J. Y. Daniel, and A. Mehta. 8 February 2006, posting date. NDPK-A (but not NDPK-B) and AMPK α1 (but not AMPK α2) bind the cystic fibrosis transmembrane conductance regulator in epithelial cell membranes. Cell. Signal. [Online.] doi:10.1016/j.cellsig.2006.01.001.
9. Dale, S., W. A. Wilson, A. M. Edelman, and D. G. Hardie. 1995. Similar substrate recognition motifs for mammalian AMP-activated protein kinase, higher plant HMG-CoA reductase kinase-A, yeast SNF1, and mammalian calmodulin-dependent protein kinase 1. FEBS Lett. 361:191-195.
10. Engel, M., M. Veron, B. Theisinger, M. L. Lacombe, T. Seib, S. Dooley, and C. Welter. 1995. A novel serine/threonine-specific protein phosphotransferase activity of Nm23/nucleoside-diphosphate kinase. Eur. J. Biochem. 234:200-207.
11. Fukuda, M., A. Ishii, Y. Yasutomo, N. Shimada, N. Ishikawa, N. Hanai, N. Nagata, T. Irimura, G. L. Nicolson, and N. Kimura. 1996. Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells. Int. J. Cancer 65:531-537.
12. Hardie, D. G., and D. Carling. 1997. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246:259-273.
13. Hardie, D. G., and S. A. Hawley. 2001. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119.
14. Hayashi, T., M. F. Hirshman, E. J. Kurth, W. W. Winder, and L. J. Goodyear. 1998. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47:1369-1373.
15. Heidbuchel, H., G. Callewaert, J. Vereecke, and E. Carmeliet. 1992. Membrane-bound nucleoside diphosphate kinase activity in atrial cells of frog, guinea pig, and human. Circ. Res. 71:808-820.
16. Ishijima, Y., N. Shimada, M. Fukuda, H. Miyazaki, N. Y. Orlov, T. G. Orlova, T. Yamada, and N. Kimura. 1999. Overexpressian of nucleoside diphosphate kinases induces neurite outgrowth and their substitution to inactive forms leads to suppression of nerve growth factor- and dibutyryl cyclic AMP-induced effects in PC12D cells. FEBS Lett. 445:155-159.
17. Jorgensen, S. B., B. Viollet, F. Andreelli, C. Frosig, J. B. Birk, P. Schjerling, S. Vaulont, E. A. Richter, and J. F. Wojtaszewski. 2004. Knockout of the alpha2 but not alpha1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 279:1070-1079.
18. Kahn, B. B., T. Alquier, D. Carling, and D. G. Hardie. 2005. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1:15-25.
19. Konig, J., R. Schreiber, M. Mall, and K. Kunzelmann. 2002. No evidence for inhibition of ENaC through CFTR-mediated release of ATP. Biochim. Biophys. Acta 1565:17-28.
20. MacDonald, N. J., A. De la Rosa, M. A. Benedict, J. M. Freije, H. Krutsch, and P. S. Steeg. 1993. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J. Biol. Chem. 268:25780-25789.
21. Merrill, G. F., E. J. Kurth, D. G. Hardie, and W. W. Winder. 1997. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273:E1107-E1112.
22. Muimo, R., Z. Hornickova, C. E. Riemen, V. Gerke, H. Matthews, and A. Mehta. 2000. Histidine phosphorylation of annexin 1 in airway epithelia. J. Biol. Chem. 275:36632-36636.
23. Nielsen, J. N., K. J. Mustard, D. A. Graham, H. Yu, C. S. MacDonald, M. Pilegaard, L. J. Goodyear, D. G. Hardie, E. A. Richter, and J. F. Wojtaszewski. 2003. 5′-AMP-activated protein kinase activity and subunit expression in exercise-trained human skeletal muscle. J. Appl. Physiol. 94:631-641.
24. Postel, E. H. 1998. NM23-NDP kinase. Int. J. Biochem. Cell Biol. 30:1291-1295.
25. Ranki, H. J., R. M. Crawford, G. R. Budas, and A. Jovanovic. 2002. Ageing is associated with a decrease in the number of sarcolemmal ATP-sensitive K+ channels in a gender-dependent manner. Mech. Ageing Dev. 123:695-705.
26. Roymans, D., R. Willems, D. R. Van Blockstaele, and H. Slegers. 2002. Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis. Clin. Exp. Metastasis 19:465-476.
27. Salt, I., J. W. Ceiler, S. A. Hawley, A. Prescott, A. Woods, D. Carling, and D. G. Hardie. 1998. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem. J. 334:177-187.
28. Schreiber, R., A. Hopf, M. Mall, R. Greger, and K. Kunzelmann. 1999. The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel. Proc. Natl. Acad. Sci. USA 96:5310-5315.
29. Stapleton, D., K. I. Mitchelhill, G. Gao, J. Widmer, B. J. Michell, T. Teh, C. M. House, C. S. Fernandez, T. Cox, L. A. Witters, and B. E. Kemp. 1996. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271:611-614.
30. Sullivan, J. E., F. Carey, D. Carling, and R. K. Beri. 1994. Characterisation of 5′-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5′-AMP analogues on enzyme activity. Biochem. Biophys. Res. Commun. 200:1551-1556.
31. Viollet, B., F. Andreelli, S. B. Jorgensen, C. Perrin, D. Flamez, J. Mu, J. F. Wojtaszewski, F. C. Schuit, M. Birnbaum, E. Richter, R. Burcelin, and S. Vaulont. 2003. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31:216-219.
32. Viollet, B., F. Andreelli, S. B. Jorgensen, C. Perrin, A. Geloen, D. Flamez, J. Mu, C. Lenzner, O. Baud, M. Bennoun, E. Gomas, G. Nicolas, J. F. Wojtaszewski, A. Kahn, D. Carling, F. C. Schult, M. J. Birnbaum, E. A. Richter, R. Burcelin, and S. Vaulont. 2003. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Investig. 111:91-98.
33. Watt, M. J., A. G. Holmes, S. K. Pinnamaneni, A. P. Garnham, G. R. Steinberg, B. E. Kemp, and M. A. Febbraio. 2006. Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 290:E500-E508.
34. Woods, A., I. Salt, J. Scott, D. G. Hardie, and D. Carling. 1996. The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett. 397:347-351.